| J0897 | Injection, denosumab, 1 mg | 11,580 | $20 | $208.4K |
| Q5112 | Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg | 3,740 | $40 | $153.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 840 | $100 | $83.1K |
| Q5114 | Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg | 1,750 | $30 | $57.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 420 | $110 | $46.1K |
| J9393 | Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg | 1,700 | $10 | $20.4K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 420 | $30 | $10.5K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 50 | $150 | $7.5K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 60 | $130 | $7.3K |
| 96402 | In this procedure, the provider administers chemotherapy either subcutaneously, meaning under the skin, or intramuscularly, meaning in muscle. He administers a hormonal anti–neoplastic drug. | 240 | $30 | $6.8K |